Clinical Trials Directory

Trials / Completed

CompletedNCT04707963

Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Auburn University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

This study will evaluate the adaptations in skeletal muscle that occur in response to 10 weeks of weight training with or without peanut protein supplementation in untrained men and women ages 18-30

Detailed description

This is a two-phase study using both novel and conventional methods to assess how PP supplementation affects muscle tissue in young adults who engage in resistance training. These two phases will be conducted as part of a 10-week randomized controlled trial in which men and women aged 18-30 years (n=40), will be stratified by gender and randomized to a resistance training intervention (whole body, two days per week) with PP powder (72g daily; n=10 males, n=10 females) provided during the intervention (immediate group, IG) or after the intervention (wait-list control, WLC, n=10 males, n=10 females). The aims of this study are to determine the acute (deuterium oxide tracer) and chronic (peripheral quantitative computed tomography) effects of PP during resistance training on skeletal muscle myofibrillar protein synthesis rates, changes in skeletal muscle size and quality, changes in whole and appendicular body composition (dual energy x-ray absorptiometry), changes in inflammatory markers and the fecal microbiome.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPeanut protein powderPeanut protein powder will be provided to participants who will be instructed to consume 72g daily, mixed with water
BEHAVIORALFull body resistance trainingParticipants will undergo supervised resistance training two times per week (5 exercises, 3 sets of 8-12 repetitions per set)

Timeline

Start date
2021-02-06
Primary completion
2021-05-31
Completion
2021-05-31
First posted
2021-01-13
Last updated
2021-06-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04707963. Inclusion in this directory is not an endorsement.